Industrial Nanotech Inc (INTK)

[bylosellhy]

Atum. I agree with your assessment and those of Biotech123. I have been playing with projections too and come to the same conclusion. Do not see how they can buy back enough shares to make a difference by end of 2022 or 2023 and not hurt the company. There are acquisition/merger plans to add new technologies that may require cash outlay. They will need to conserve cash for that. We need to question in the May 26 Zoom call his assumptions and plans to use cash generated this and next year On the other hand, maybe he sees the potential of even greater revenue or other cash influx that he hasn't included in his projections and is not appropriate to talk about at this point.